Opus-M Health: Dermatitis for Mobile
Artificial Life, Inc., a leading provider of award-winning mobile technology and applications, announced today their upcoming product Opus-M Health: Dermatitis, a healthcare app specifically geared towards the monitoring of the dermatitis skin condition.
Dermatitis is any condition characterized by inflammation of the skin and affects both males and females equally. In the United States, 1 in 30 (or approximately 8 million) people are affected.* While there are various types of dermatitis, all share some common symptoms such as itching, lesions, swelling, and occasional weeping of fluids from the skin. All of these symptoms may be monitored and recorded using Artificial Life (ALIFE)’s Opus-M Health: Dermatitis app.
Opus-M Health: Dermatitis includes a slideshow function for recording pictures of skin conditions and allows for PDF sharing of records via iTunes. Using Opus-M Health: Dermatitis, patients are able to record their skin conditions with more than 10 attribute options such as lesions, distribution, surface texture, and more. In addition, the app contains a body mapping feature to provide a clear and comprehensive indication of affected areas throughout the body. Overall, the Opus-M Health: Dermatitis app allows users to effectively keep track of their dermatitis-related body conditions and easily share this information with their doctors and caregivers.
Features of Opus-M Health: Dermatitis include:
- Ability to track over 10 core characteristics of inflammation/rashes to provide a more in-depth picture of skin conditions
- Body mapping feature to show specific areas affected by dermatitis
- Simple and easy-to-use data input for photo and text recordings
- A slideshow function to show changes of the condition and healing process over time
- An interactive graph to track and visualize measurements of areas of the skin being monitored
- PDF summaries of data that can be exported to patients and caregivers medical records via iTunes sharing
- Health tips on skin care to minimize the effects of dermatitis
As with all applications in the Opus-M Health family, Opus-M Health: Dermatitis will leverage Artificial Life’s Opus-M platform for end-consumers, healthcare providers, and healthcare businesses. The app is scheduled to launch on the Apple App Store in Q2 2011 pending approval and will be available later for Android and Windows Phone 7.
Opus-M Health: Dermatitis follows the Company’s successful launch of GluCoMo, its diabetes monitoring app, and Opus-M Health: Neurodermatitis. Artificial Life’s Opus-M Health platform will continue to expand and feature more healthcare apps such as the previously announced upcoming apps: Opus-M Health: Neurodermatitis Kids Edition, an expansion of the Opus-M healthcare skin app developed specifically for children affected by neurodermatitis; and Opus-M Health: HIV/AIDS, a healthcare app that is used for the monitoring of HIV/AIDS. More information about apps by Artificial Life can be found at www.botme.com and www.artificial-life.com.
“We are delighted to introduce Opus-M Health: Dermatitis into the Opus-M Health family. With its new features such as the body mapping function, this application shows Artificial Life’s constant efforts to enhance the capabilities of its products to better meet the needs of users,” said Eberhard Schoneburg, CEO of Artificial Life, Inc.
*Source:
1. “Prevalence and Incidence of Dermatitis,” CureResearch.com, May 31, 2011. http://www.cureresearch.com/d/dermatitis/prevalence_printer.htm
App Store is a service mark of Apple Inc.
Android is a trademark of Google Inc. Use of this trademark is subject to Google Permissions.
Windows is a registered trademark of Microsoft Corporation in the United States and/or other countries.
See Also:
If you enjoyed this post, please consider leaving a comment, subscribe to the feed and get future articles delivered to your feed reader or follow us on Twitter.
Comments
No comments yet.
Leave a comment